Eliem Therapeutics, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€0.00 - Gross profit
€0.00 - SG&A expenses
€20.45M - R&D expenses
€33.52M - EBITDA
-€54.53M - D&A
-€5.22M - EBIT
-€98.74M - Interest expenses
-€989.06K - EBT
-€44.81M - Tax expenses
€2.59M - Net income
-€44.81M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€1.87M - Changes in working capital
-€3.51M - Operating cash flow
-€39.86M - Capex
€66.34K - Other investing cash flow
€0.00 - Net investing cash flow
-€234.08M - Total cash dividends paid
€0.00 - Issuance of common stock
-€7.72M - Debt repayment
€0.00 - Other financing cash flow
€11.42M - Net financing cash flow
€3.70M - Foreign exchange effects
€421.30K - Net change in cash
-€239.01M - Cash at end of period
€19.54M - Free cash flow
-€39.79M
Balance sheet
- Cash and cash equivalents
€19.54M - Cash and short-term investments
€72.98M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€2.31M - Total current assets
€75.29M - Property, plant & equipment
€802.96K - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€0.00 - Other non-current assets
€89.66M - Total non-current assets
€90.46M - Total assets
€165.75M - Accounts payable
€815.03K - Short-term debt
€191.26K - Other current liabilities
€4.34M - Total current liabilities
€5.35M - Long-term debt
€359.27K - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€359.27K - Total liabilities
€5.71M - Common stock
€6.03K - Retained earnings
-€223.42M - Other equity
€273.97K - Total equity
€160.04M - Total liabilities and shareholders' equity
€165.75M
Company information
- Market capitalization
€292.29M - Employees
9 - Enterprise Value
-€1.55M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-28.0% Much better than peer group: -185.2% - ROA
-
-27.0% Much better than peer group: -291.7% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-13.7% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€4.98M